Zhang, Zijie http://orcid.org/0000-0002-4900-506X
Luo, Kaixuan
Zou, Zhongyu http://orcid.org/0000-0001-7152-5435
Qiu, Maguanyun
Tian, Jiakun
Sieh, Laura http://orcid.org/0000-0003-3238-016X
Shi, Hailing
Zou, Yuxin
Wang, Gao
Morrison, Jean http://orcid.org/0000-0003-4829-8283
Zhu, Allen C. http://orcid.org/0000-0002-1490-7063
Qiao, Min
Li, Zhongshan
Stephens, Matthew http://orcid.org/0000-0001-5397-9257
He, Xin http://orcid.org/0000-0001-9011-5212
He, Chuan http://orcid.org/0000-0003-4319-7424
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1HG008935, HG002585)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH110531)
Article History
Received: 13 March 2019
Accepted: 11 May 2020
First Online: 29 June 2020
Competing interests
: C.H. is a founder and scientific advisory board member of Accent Therapeutics and a shareholder of Epican Genentech.